Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The Ozempic prescribing information includes a warning about acute kidney injury and worsening of existing kidney problems, and states that "a majority of the reported events occurred in patients who had experienced nausea, vomiting, diarrhea, or dehydration." The same label tells doctors to counsel patients "of the potential risk of dehydration due to gastrointestinal adverse reactions and take precautions to avoid fluid depletion." The Mounjaro label carries the same class warning and advises doctors to "monitor renal function in patients reporting adverse reactions to MOUNJARO that could lead to volume depletion." It helps to keep this in perspective
Research Use Only: All peptide products sold by Frontier Peptide Labs are intended exclusively for laboratory research and development purposes
As with any medical treatment, it's important to consult with a healthcare provider to discuss risks, benefits, and the most suitable treatment for your specific needs
Medicare bars it by law
Quick Answer: The right GLP-1 medication for you depends on your cardiovascular status, weight management goals, dosing preference (daily versus weekly), renal function, and insurance coverage
Tirzepatide is a type of adjunct-to-insulin therapy for diabetes called GLP-1RAs, short for glucagon-like peptide-1 (GLP-1) receptor agonist
